Logo DoctorsConnect

Your medical data, safe and secure.

Name

Afatinib

Description

Afatinib is a tyrosine kinase inhibitor which is a 4-anilinoquinazoline. It is prepared has the dimaleate salt. FDA approved on July 12, 2013.

Brands

No brand information found.